Back to Search
DAWN ENGELHARDT, PHARMD
PHARMD
Pharmacist
NPI: 1952792616Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
16382-40(WI)
Research & Publications (20)
Accurate mass determinations in decay chains with missing energy.
PMID 18643654·Phys Rev Lett·2008
8-other
Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity.
PMID 17318079·Transplantation·2007
7-preclinical
Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels.
PMID 16261527·J Pathol·2006
7-preclinical
Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping.
PMID 16482497·J Pathol·2006
7-preclinical
Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activation.
PMID 16310278·J Hepatol·2006
4-observational
Glucocerebroside ameliorates the metabolic syndrome in OB/OB mice.
PMID 16815870·J Pharmacol Exp Ther·2006
7-preclinical
Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes.
PMID 15976388·Am J Physiol Gastrointest Liver Physiol·2005
7-preclinical
Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes.
PMID 15558045·Bone Marrow Transplant·2005
7-preclinical
Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes.
PMID 15688366·Int J Cancer·2005
7-preclinical
Role of the intracellular receptor domain of gp130 (exon 17) in human inflammatory bowel disease.
PMID 15754404·World J Gastroenterol·2005
8-other
Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect.
PMID 15784461·Hum Immunol·2005
7-preclinical
Oral immune regulation using colitis extracted proteins for treatment of Crohn's disease: results of a phase I clinical trial.
PMID 15918198·World J Gastroenterol·2005
3-trial
Suppression of hepatocellular carcinoma growth via oral immune regulation towards tumor-associated antigens is associated with increased NKT and CD8+ lymphocytes.
PMID 15218301·Oncology·2004
7-preclinical
Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators?
PMID 15249728·Neuroimmunomodulation·2004
4-observational
Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis.
PMID 14557387·J Leukoc Biol·2004
7-preclinical
Expression of novel neurotrophin-1/B-cell stimulating factor-3 (NNT-1/BSF-3) in murine pituitary folliculostellate TtT/GF cells: pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-induced stimulation of NNT-1/BSF-3 is mediated by protein kinase A, protein kinase C, and extracellular-signal-regulated kinase1/2 pathways.
PMID 14605001·Endocrinology·2004
7-preclinical
The oncostatin M receptor/gp130 ligand murine oncostatin M induces apoptosis in adrenocortical Y-1 tumor cells.
PMID 15012602·J Endocrinol·2004
7-preclinical
The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation.
PMID 15093555·Clin Immunol·2004
7-preclinical
Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial.
PMID 15287852·Liver Int·2004
3-trial
Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins.
PMID 14638356·Am J Gastroenterol·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 405 N WALES RD
WALES, WI 53183 - Phone
- (262) 968-9570
Quick Facts
- NPI
- 1952792616
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile